The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Chronic Pain Treatment Market Between 2026 And 2030?
The chronic pain treatment market size has experienced substantial expansion in recent years. It is anticipated to increase from $109.05 billion in 2025 to $119.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this growth can be ascribed to factors such as opioid usage, musculoskeletal disorders, an aging population, the presence of hospital pain clinics, and post-surgical pain management.
The chronic pain treatment market size is anticipated to experience significant expansion in the coming years, projected to reach $168.99 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.1%. This projected growth during the forecast period is attributable to factors such as opioid regulation, the development of device-based therapies, the rising prevalence of chronic diseases, increased mental health integration, and the expansion of outpatient pain care. Noteworthy trends for the forecast period include a shift towards non-opioid pain therapies, the increasing adoption of neuromodulation devices, the broadening of multidisciplinary pain management strategies, a greater emphasis on personalized pain care, and the integration of psychological support therapies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp
What Key Factors Are Shaping The Chronic Pain Treatment Market Landscape?
The increasing occurrence of arthritis pain is anticipated to drive the expansion of the chronic pain treatment market in the future. Arthritis pain describes the unease, throbbing, or tenderness experienced in joints, resulting from inflammation or deterioration linked to arthritis. The growing incidence of arthritis pain is largely fueled by the older demographic, given that natural joint wear and tear escalates with age, contributing to a higher occurrence of arthritis-related issues. Chronic pain treatment addresses arthritis pain by focusing on inflammation and nerve sensitivity, aiming to lessen discomfort, enhance joint mobility, and elevate the overall quality of life for those experiencing ongoing arthritis symptoms. As an illustration, in July 2024, data from the Centers for Disease Control and Prevention, a US-based government body, indicated that approximately 21.2% of adults aged 18 and above in the US had received an arthritis diagnosis in 2023. Consequently, the increasing prevalence of arthritis pain is a significant factor in the growth of the chronic pain treatment market.
What Are The Key Segment Divisions In The Chronic Pain Treatment Market Segment Structure?
The chronic pain treatment market covered in this report is segmented –
1) By Product Type: Drugs, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By Distribution channels: Direct, Indirect
4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications
2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices
What Trends Are Affecting The Direction Of The Chronic Pain Treatment Market?
Major companies within the chronic pain treatment market are concentrating on developing innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems, to address the increasing demand for advanced non-opioid therapies, improved long-term pain control, and enhanced patient quality of life. Closed-loop SCS systems are implantable, rechargeable neurostimulators designed to continuously monitor neural signals and automatically adjust electrical stimulation in real time, unlike traditional open-loop SCS devices that deliver predetermined and non-responsive output. For instance, in April 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv Neurostimulation System. This device is a compact, rechargeable implant that utilizes sensing electrodes to observe evoked neural responses and automatically regulate stimulation. It offers full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain. The system is engineered to provide more consistent pain relief, better responder outcomes, and improved comfort compared to conventional fixed-output SCS systems.
Which Organizations Are Engaged In The Chronic Pain Treatment Market?
Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.
Get The Full Chronic Pain Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report
Which Region Accounts For The Largest Portion Of The Chronic Pain Treatment Market?
North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Chronic Pain Treatment Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report
Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company
Chronic Pain Market Report 2026
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report
Pain Management Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
Cold Pain Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model